These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 19828360)

  • 1. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis.
    Sonis ST
    Oral Oncol; 2009 Dec; 45(12):1015-20. PubMed ID: 19828360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral mucositis.
    Raber-Durlacher JE; Elad S; Barasch A
    Oral Oncol; 2010 Jun; 46(6):452-6. PubMed ID: 20403721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral mucositis in cancer therapy.
    Sonis ST
    J Support Oncol; 2004; 2(6 Suppl 3):3-8. PubMed ID: 15605918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evidence based care in the prevention and treatment of mucositis induced by chemo- and radiotherapy].
    Salgarello MC
    Assist Inferm Ric; 2003; 22(2):95-106. PubMed ID: 13677166
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.
    Scully C; Epstein J; Sonis S
    Head Neck; 2003 Dec; 25(12):1057-70. PubMed ID: 14648865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral mucositis. A complication of radiotherapy.
    Rider CA
    N Y State Dent J; 1990 Nov; 56(9):37-9. PubMed ID: 1701229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of oral mucositis induced by chemotherapy and radiotherapy: an update.
    Vélez I; Tamara LA; Mintz S
    Quintessence Int; 2004 Feb; 35(2):129-36. PubMed ID: 15000636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging therapies for the prevention and treatment of oral mucositis.
    Yuan A; Sonis S
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):343-51. PubMed ID: 25102771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.
    Demarosi F; Bez C; Carrassi A
    Minerva Stomatol; 2002 May; 51(5):173-86. PubMed ID: 12070468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucositis: biology and management.
    Treister N; Sonis S
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):123-9. PubMed ID: 17413415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New strategies for management of oral mucositis in cancer patients.
    Peterson DE
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):9-13. PubMed ID: 16499139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis.
    McDonnell AM; Lenz KL
    Ann Pharmacother; 2007 Jan; 41(1):86-94. PubMed ID: 17190850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
    Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
    N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical curcumin for the prevention of oral mucositis in pediatric patients: case series.
    Elad S; Meidan I; Sellam G; Simaan S; Zeevi I; Waldman E; Weintraub M; Revel-Vilk S
    Altern Ther Health Med; 2013; 19(3):21-4. PubMed ID: 23709456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucositis: pathobiology and management.
    Villa A; Sonis ST
    Curr Opin Oncol; 2015 May; 27(3):159-64. PubMed ID: 25774860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
    Rosen LS; Abdi E; Davis ID; Gutheil J; Schnell FM; Zalcberg J; Cesano A; Gayko U; Chen MG; Clarke S
    J Clin Oncol; 2006 Nov; 24(33):5194-200. PubMed ID: 17075109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucositis: current management and investigations.
    Garden AS
    Semin Radiat Oncol; 2003 Jul; 13(3):267-73. PubMed ID: 12903015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
    Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
    J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies.
    Aksungur P; Sungur A; Unal S; Iskit AB; Squier CA; Senel S
    J Control Release; 2004 Aug; 98(2):269-79. PubMed ID: 15262418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.